GDRX
GoodRx Holdings, Inc.NASDAQHealthcare$2.05+1.99%ClosedMarket Cap: $702.5M
As of 2026-04-06
Valuation
P/E (TTM)
23.08
PEG
0.99
P/B
1.13
P/S
0.88
EV/EBITDA
2.71
DCF Value
$4.58
FCF Yield
15.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
82.1%
Operating Margin
11.2%
Net Margin
3.8%
ROE
4.8%
ROA
3.3%
ROIC
4.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $194.8M | 57.5% | $41.3M | $5.4M | $0.02 | — |
| FY 2025 | $796.9M | 82.1% | $107.0M | $30.4M | $0.09 | — |
| Q3 2025 | $196.0M | 93.2% | $14.6M | $1.1M | $0.00 | — |
| Q2 2025 | $203.1M | 83.7% | $27.7M | $12.8M | $0.04 | — |
| Q1 2025 | $203.0M | 93.4% | $23.4M | $11.1M | $0.03 | — |
| Q4 2024 | $198.6M | 93.9% | $18.2M | $6.7M | $0.02 | — |
| FY 2024 | $792.3M | 93.9% | $65.8M | $16.4M | $0.04 | — |
| Q3 2024 | $195.3M | 94.0% | $20.4M | $12.3M | $0.03 | — |
| Q2 2024 | $200.6M | 94.1% | $19.9M | $6.7M | $0.02 | — |
| Q1 2024 | $197.9M | 93.7% | $7.4M | $-1.0M | $-0.00 | — |
| Q4 2023 | $196.6M | 92.3% | $-18.3M | $-25.9M | $-0.06 | — |
| FY 2023 | $750.3M | 91.1% | $-27.0M | $-8.9M | $-0.02 | — |